In historic vote, mRNA vaccines go 2 and 0 as FDA experts unanimously back Moderna's Covid-19 vaccine

Come Saturday, the U.S. will likely have two Covid-19 vaccines.

The FDA’s advisory committee on vaccines voted unanimously Thursday — with one abstention — to recommend an emergency use authorization for Moderna’s mRNA-based Covid-19 shot, setting the agency up to likely issue the EUA on Friday. The agency does not have to listen to the committee but usually does.